Department of Molecular Oncology and Pharmacogenetics, National University of Córdoba, Córdoba, Argentina
Opinion Article
Pharmacogenetic Variants in DPYD and the Risk of Fluoropyrimidine Toxicity in Cancer Therapy
Author(s): Juliana Ortega*